FDA Draft Guidance for Industry on Establishing Sanitation Programs for Low-Moisture Ready-to-Eat Human Foods Webinar
This webinar was presented by Maile Gradison, ASTA's General Counsel and partner at Hogan Lovells, and Anneke Altieri, Senior Associate with Hogan Lovells. The presentation will review FDA draft guidance published on January 6, 2025, intended to help manufacturers of Low-Moisture Ready-to-Eat (LMRTE) human foods, such as spices, establish sanitation programs and take appropriate corrective actions following a pathogen contamination event.
Membership Required
A valid ASTA membership is required to access this page. Please use the form below to log in with your ASTA member account.
Log in
Not a member yet? Click here to learn about joining ASTA today.
Related Resources
2019 Regulatory Presentation: FDA Priorities
This presentation was provided at the 2019 Regulatory Workshop. The presenter, Mark Moorman, presented an annual update to ASTA about FDA's upcoming priorities, including observations, a new era of food safety, and facility inspections.
A Closer Look at FDA’s Guidance on Food Allergens Webinar
Presented on Friday, July 26, 2024. Undeclared allergens continue to be the leading cause of food recalls, and allergen control programs are commonly cited in 483s and Warning Letters. In the fall of 2023, the FDA released Chapter 11 of FDA’s Hazard Analysis and Risk-Based Preventive Controls for Human Food draft guidance, which addresses the FDA’s current thinking on how to develop and implement robust allergen preventive controls and cGMP programs. Additionally, in the fall of 2022, the FDA issued two guidance documents about food allergen labeling, including notable recommendations on allergen advisory labeling issues. In this webinar, Maile Gradison and Anneke Altieri will offer a deep dive into these guidance documents and share insight into the FDA’s expectations for allergen management programs, including label content and controls, supplier verification activities, advisory allergen labeling, and cGMPs.
